Veröffentlichungsdatum: 08/04/2026
Prague hosted the 2026 European Psychiatric Association (EPA) Congress, a fitting location given the growing adoption of Transcranial Magnetic Stimulation (TMS) in the Czech Republic and across Europe. As TMS becomes a mainstream alternative to traditional therapies, DEYMED Diagnostic was on hand to showcase our latest neurostimulation solutions.
The event provided a productive space to reconnect with our global community of long-term customers and engage with new participants interested in expanding the use of TMS for various psychiatric indications.
Thank you to everyone who visited the DEYMED booth, we look forward to seeing you at the next one!
